Shared Facilities

In Vivo Therapeutics Core

"index.shtml", "Policies and Procedures" => "policies.shtml", "Examples" => "example.shtml", "Services" =>"services.shtml", "Request for Services" => "form.shtml", "Contact" => "contact.shtml" ); $strLinks = "
"; foreach($arrLinks as $key => $val){ $extra = ""; //if((strlen($key) <= 8)){ //$extra= "style=\"padding-top:10px;padding-bottom:-10px;\"";} if (!(preg_match("/".$val."/",$_SERVER["PHP_SELF"]))){ $class = "spn_fac_nav"; }else { $class = "spn_fac_nav_highlgt"; } $handle = @fopen($val,'r'); if($handle !== false){ $strLinks .= "".$key.""; } } if ((preg_match("/mac/",$_SERVER["PHP_SELF"]))){ $strLinks .= "Request Form"; } echo $strLinks."
"; echo ""; ?>

The mission of the In Vivo Therapeutics (IVT) Core is to provide IUSCC investigators with cost-effective and comprehensive services to facilitate the development and testing of novel pharmacological and cellular therapies.

  • The following mouse strains are available from the on-site breeding facility: NOD/SCID, NOD/SCID/IL2Rgammanull, Boy/J, and F1/BoyJxC57Bl/6.
  • All animal studies must be pre-approved by the Institutional Animal Care and Use Committee (IACUC). The core maintains a IACUC-approved study dedicated to in vivo animal studies. If needed, the core director will work with the principal investigator to construct and submit their animal study amendment.
  • The core will act as a liaison between the principal investigator and any other outcome analyses from live phase study.
  • Study design and deliverables can be modified to suit the requirements of a specific animal study.